# Progress Note 01 — Initial plan

> **SYNTHETIC RECORD, NOT A REAL MEDICAL RECORD**

- Patient: John Locke (real historical name used in a fictional teaching record)
- Synthetic MRN: HR-EN001-SYN-TD
- Date: 1692-03-12
- Fictional facility: St. Posthumous Health Center
- Fictional author: Prudence Hartwell-Osei, MD
- Calendar frame: true historical dates (modern content is anachronistic)

> True-date frame: synthetic events are moved into the patient's historical lifetime. Codes, instruments, and treatments remain modern and are anachronistic.

## Subjective

The patient participates in this fictional visit for primary care visit for a lifelong cough with wheeze and breathlessness, worse in city air and by open fires, in a never-smoker. **S**

## Objective

Asthma Control Test: 12; PHQ-2: 1; Hemoglobin: 14.8 g/dL; White blood cells: 7.4 10*3/uL; Blood eosinophils: 0.46 10*3/uL; Platelets: 251 10*3/uL; Total IgE: 186 [IU]/mL (high); Alpha-1 antitrypsin: 131 mg/dL; NT-proBNP: 58 pg/mL; Interferon-gamma release assay (TB1 antigen minus nil): 0.02 [IU]/mL. All results are synthetic.

BP 122/74 mmHg; pulse 84 bpm; respirations 18/min; temperature 36.6 °C; oxygen saturation 95% on room air; weight 62 kg; BMI 19.6 kg/m². All vital signs are synthetic.

## Assessment

Active problems: Chronic cough with wheeze and breathlessness since his late thirties, worse every winter and within a day of any stay in the city or by an open fire, better in warm weather and country air; night cough two or three times a week this winter; under evaluation; Long exposure to urban air pollution (decades in a large city with heavy traffic and coal and wood burning) and to indoor solid-fuel smoke from open coal and wood fires at home. Strengths and supports remain part of the care plan. **S**

## Medication changes

- Started: Albuterol 90 mcg/actuation inhaler, two puffs every 4 hours as needed while tests are done; hold for 6 hours before spirometry **S**

## Plan

- Diagnostic workup: spirometry before and after bronchodilator, FeNO, DLCO, blood count with eosinophils, total IgE, alpha-1 antitrypsin, NT-proBNP, interferon-gamma release assay, chest X-ray, and CT of the chest if airflow limitation persists after bronchodilator; albuterol withheld for 6 hours before testing. Guideline: CMID: Clinical Monitoring Intelligence Database, asthma and COPD monographs (2026); Global Strategy for Asthma Management and Prevention, 2025 update (2025); 2020 Focused Updates to the Asthma Management Guidelines: A Report from the National Asthma Education and Prevention Program Coordinating Committee Expert Panel Working Group (2020); Global Strategy for the Prevention, Diagnosis and Management of COPD: 2025 Report (2025); Stanojevic S, et al. ERS/ATS technical standard on interpretive strategies for routine lung function tests. Eur Respir J 2022;60(1):2101499 (PMID 34949706) (2022); Bhakta NR, et al. Race and Ethnicity in Pulmonary Function Test Interpretation: An Official American Thoracic Society Statement. Am J Respir Crit Care Med 2023;207(8):978-995 (PMID 36973004) (2023) **S**
- Exposure reduction from today: no open coal or wood fires in his rooms (electric or heat-pump heating instead); a portable HEPA air cleaner sized for his study and bedroom; daily check of the air quality index, with city trips and outdoor exertion avoided on alert days; a well-fitted N95 respirator on unavoidable high-pollution days; quieter routes away from main roads. Guideline: CMID: Clinical Monitoring Intelligence Database, asthma and COPD monographs (2026); Global Strategy for Asthma Management and Prevention, 2025 update (2025); 2020 Focused Updates to the Asthma Management Guidelines: A Report from the National Asthma Education and Prevention Program Coordinating Committee Expert Panel Working Group (2020); WHO global air quality guidelines: particulate matter (PM2.5 and PM10), ozone, nitrogen dioxide, sulfur dioxide and carbon monoxide (2021); Carlsten C, et al. Personal strategies to minimise effects of air pollution on respiratory health: advice for providers, patients and the public. Eur Respir J 2020;55(6):1902056 (PMID 32241830) (2020); AQI Basics (2026); Air Cleaners and Air Filters in the Home (2026) **S**
- Pulmonology consultation on the diagnosis (asthma, COPD, or both), the need for CT, treatment, and pulmonary rehabilitation. Guideline: CMID: Clinical Monitoring Intelligence Database, asthma and COPD monographs (2026); Global Strategy for Asthma Management and Prevention, 2025 update (2025); 2020 Focused Updates to the Asthma Management Guidelines: A Report from the National Asthma Education and Prevention Program Coordinating Committee Expert Panel Working Group (2020); Global Strategy for the Prevention, Diagnosis and Management of COPD: 2025 Report (2025) **S**
- Vaccinations: pneumococcal conjugate vaccine PCV20 at the diagnosis visit; influenza, COVID-19, and RSV vaccines in the autumn; recombinant zoster vaccine. Guideline: CMID: Clinical Monitoring Intelligence Database, asthma and COPD monographs (2026); Adult Immunization Schedule by Age (2026) **S**
- Monitoring: Asthma Control Test, inhaler technique, adherence, reliever use, and exposures at every visit; spirometry and FeNO 3 months after starting treatment, then every 1 to 2 years; home peak flow diary. Guideline: CMID: Clinical Monitoring Intelligence Database, asthma and COPD monographs (2026); Global Strategy for Asthma Management and Prevention, 2025 update (2025); 2020 Focused Updates to the Asthma Management Guidelines: A Report from the National Asthma Education and Prevention Program Coordinating Committee Expert Panel Working Group (2020) **S**
